These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species. Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960 [TBL] [Abstract][Full Text] [Related]
24. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D. Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Tomic MT; Espinoza Y; Martinez Z; Pham K; Cobb RR; Snow DM; Earnhart CG; Pals T; Syar ES; Niemuth N; Kobs DJ; Farr-Jones S; Marks JD Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959899 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A. Brier S; Rasetti-Escargueil C; Wijkhuisen A; Simon S; Marechal M; Lemichez E; Popoff MR FASEB J; 2021 May; 35(5):e21540. PubMed ID: 33817838 [TBL] [Abstract][Full Text] [Related]
27. The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA. Fan Y; Barash JR; Conrad F; Lou J; Tam C; Cheng LW; Arnon SS; Marks JD Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877649 [TBL] [Abstract][Full Text] [Related]
28. Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F. Fan Y; Sun Z; Conrad F; Wen W; Zhao L; Lou J; Zhou Y; Farr-Jones S; Marks JD PLoS One; 2022; 17(9):e0273512. PubMed ID: 36048906 [TBL] [Abstract][Full Text] [Related]
29. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E. Bever CS; Scotcher M; Cheng LW; Hnasko RM; Stanker LH Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31337022 [TBL] [Abstract][Full Text] [Related]
30. Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E. Miethe S; Rasetti-Escargueil C; Avril A; Liu Y; Chahboun S; Korkeala H; Mazuet C; Popoff MR; Pelat T; Thullier P; Sesardic D; Hust M PLoS One; 2015; 10(10):e0139905. PubMed ID: 26440796 [TBL] [Abstract][Full Text] [Related]
31. Botulinum neurotoxins and botulism: a novel therapeutic approach. Thanongsaksrikul J; Chaicumpa W Toxins (Basel); 2011 May; 3(5):469-88. PubMed ID: 22069720 [TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries. Amersdorfer P; Wong C; Chen S; Smith T; Deshpande S; Sheridan R; Finnern R; Marks JD Infect Immun; 1997 Sep; 65(9):3743-52. PubMed ID: 9284147 [TBL] [Abstract][Full Text] [Related]
33. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B. Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791 [TBL] [Abstract][Full Text] [Related]
34. A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model. Snow DM; Cobb RR; Martinez J; Finger-Baker I; Collins L; Terpening S; Syar ES; Niemuth N; Kobs D; Barnewall R; Farr-Jones S; Marks JD; Tomic MT Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466411 [TBL] [Abstract][Full Text] [Related]
35. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A. Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358 [TBL] [Abstract][Full Text] [Related]
36. Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain. Avril A; Miethe S; Popoff MR; Mazuet C; Chahboun S; Rasetti-Escargueil C; Sesardic D; Thullier P; Hust M; Pelat T BMC Biotechnol; 2015 Sep; 15():86. PubMed ID: 26382731 [TBL] [Abstract][Full Text] [Related]
37. Antagonism of the intracellular action of botulinum neurotoxin type A with monoclonal antibodies that map to light-chain epitopes. Cenci Di Bello I; Poulain B; Shone CC; Tauc L; Dolly JO Eur J Biochem; 1994 Jan; 219(1-2):161-9. PubMed ID: 7508383 [TBL] [Abstract][Full Text] [Related]
38. Identifying the principal protective antigenic determinants of type A botulinum neurotoxin. Bavari S; Pless DD; Torres ER; Lebeda FJ; Olson MA Vaccine; 1998 Nov; 16(19):1850-6. PubMed ID: 9795391 [TBL] [Abstract][Full Text] [Related]